The Court of Justice of the European Communities rejects the Commission’s appeal against the annulment of the rejection of exemption’s application (GlaxoSmithKline)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The general terms and conditions of sale applied by a drug manufacturer to its wholesalers implied, because of a differential pricing system, more onerous conditions when the products were intended for export. Since the agreement had the object of restricting parallel trade, the cartel infringement was initially upheld